PEPTONIC medical AB (FRA:28L) Common Stock: €0.19 Mil (As of Mar. 2026)


What is PEPTONIC medical AB Common Stock?

PEPTONIC medical AB FRA:28L Common Stock is €0.19 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

PEPTONIC medical AB's quarterly common stock increased from Sep. 2025 (€3.90 Mil) to Dec. 2025 (€3.95 Mil) but then declined from Dec. 2025 (€3.95 Mil) to Mar. 2026 (€0.19 Mil).

PEPTONIC medical AB's annual common stock increased from Dec. 2023 (€3.43 Mil) to Dec. 2024 (€3.51 Mil) and increased from Dec. 2024 (€3.51 Mil) to Dec. 2025 (€3.95 Mil).

PEPTONIC medical AB Common Stock Historical Data

* Premium members only.

The historical data trend for PEPTONIC medical AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB Common Stock Chart

PEPTONIC medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.87 2.21 3.43 3.51 3.95

PEPTONIC medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.94 3.90 3.90 3.95 0.19

PEPTONIC medical AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.19 Mil mean?
PEPTONIC medical AB (FRA:28L) has a Common Stock of €0.19 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PEPTONIC medical AB and its competitors.
Is PEPTONIC medical AB's Common Stock too high?
PEPTONIC medical AB's current Common Stock is €0.19 Mil.
How does PEPTONIC medical AB's Common Stock compare to ZTS and UTHR?
PEPTONIC medical AB's Common Stock of €0.19 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PEPTONIC medical AB and its competitors. PEPTONIC medical AB's current Common Stock is €0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PEPTONIC medical AB stock overvalued right now?
PEPTONIC medical AB (FRA:28L) has a current Common Stock of €0.19 Mil. The current Common Stock is €0.19 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PEPTONIC medical AB (FRA:28L), the current Common Stock is €0.19 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PEPTONIC medical AB Business Description

Other Exchanges PMED:Sweden
Address Gustavslundsvagen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.